Mutagen sensitivity in common cutaneous malignant melanoma and dysplastic naevus syndrome

被引:4
作者
Cloos, J
Willems, EM
van Warmerdam, JMB
Braakhuis, BJM
Snow, GB
Meijer, S
机构
[1] Univ Hosp Vrije, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Univ Hosp Vrije, Dept Gen Surg, NL-1007 MB Amsterdam, Netherlands
关键词
dysplastic naevus; melanoma; molecular epidemiology; mutagen sensitivity; susceptibility;
D O I
10.1097/00008390-199906000-00011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Sunlight (ultraviolet radiation) has been identified as the major environmental risk factor for the development of cutaneous malignant melanoma and dysplastic naevi. This is, however, not sufficient to explain all melanoma cases. In recent years much emphasis has been given to genetic susceptibility to melanoma. A biomarker of susceptibility to environmentally related cancer is mutagen sensitivity. This is measured as the number of chromatid breaks in lymphocytes which are exposed to bleomycin in the G(2) phase of the cell cycle. It has been described that patients with common melanoma show an increased mutagen sensitivity compared with controls. In the present study mutagen sensitivity was measured in 10 dysplastic naevus syndrome patients and compared with that in 11 patients with common melanoma. We found similar results for common melanoma patients as have been reported earlier: a relatively high mean breaks per cell value (0.93 +/- 0.31). In contrast, melanoma patients with dysplastic naevi showed a significantly (P<0.01) lower mutagen sensitivity value (0.46 +/- 0.34). This phenomenon was even more pronounced when only hereditary dysplastic naevi patients (one or more family members with dysplastic naevi) were considered (n=5; 0.24 +/- 0.05). These results suggest a difference in the initiation of the carcinogenic process in melanoma with a dysplastic naevus as a precursor and melanoma without dysplastic naevi. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:292 / 296
页数:5
相关论文
共 28 条
[1]
BENDER MA, 1988, CANCER RES, V48, P2579
[2]
CannonAlbright LA, 1996, SEMIN ONCOL, V23, P667
[3]
Cascorbi I, 1996, CANCER RES, V56, P3961
[4]
Influence of the antioxidant N-acetylcysteine and its metabolites on damage induced by bleomycin in PM2 bacteriophage DNA [J].
Cloos, J ;
Gille, JJP ;
Steen, I ;
Lafleur, MVM ;
Retel, J ;
Snow, GB ;
Braakhuis, BJM .
CARCINOGENESIS, 1996, 17 (02) :327-331
[5]
Genetic susceptibility to head and neck squamous cell carcinoma [J].
Cloos, J ;
Spitz, MR ;
Schantz, SP ;
Hsu, TC ;
Zhang, ZF ;
Tobi, H ;
Braakhuis, BJM ;
Snow, GB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (08) :530-535
[6]
CUTANEOUS MALIGNANT-MELANOMA - EPIDEMIOLOGIC CONSIDERATIONS [J].
FRANCESCHI, S ;
CRISTOFOLINI, M .
SEMINARS IN SURGICAL ONCOLOGY, 1992, 8 (06) :345-352
[7]
Screening for CDKN2A mutations in hereditary melanoma [J].
Goldstein, AM ;
Tucker, MA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (10) :676-678
[8]
HIGH-RISK OF MALIGNANT-MELANOMA IN MELANOMA-PRONE FAMILIES WITH DYSPLASTIC NEVI [J].
GREENE, MH ;
CLARK, WH ;
TUCKER, MA ;
KRAEMER, KH ;
ELDER, DE ;
FRASER, MC .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (04) :458-465
[9]
Genetics of cutaneous melanoma and nevi [J].
Greene, MH .
MAYO CLINIC PROCEEDINGS, 1997, 72 (05) :467-474
[10]
NORMAL REACTIVATION OF PLASMID DNA INACTIVATED BY UV IRRADIATION BY LYMPHOCYTES FROM INDIVIDUALS WITH HEREDITARY DYSPLASTIC NEVUS SYNDROME [J].
HANSSON, J ;
LOOW, H .
MELANOMA RESEARCH, 1994, 4 (03) :163-167